Guido Freckmann, MD
Institute for Diabetes Technology GmbH, Ulm, Germany
Dr. Guido Freckmann, MD, is Medical Director and General Manager of the “Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm” (IfDT), Ulm, Germany. The IfDT is an independent research organization specialized to diabetes technology. The IfDT is accredited and internationally renowned as testing laboratory for BGMS following ISO 15197.
Dr. Freckmann is diabetologist of the German Diabetes Association.
As a study physician at the IfDT, he was principle investigator for different studies, about e.g. CGM systems, development of closed loop systems or insulin pumps, and cooperates with several industrial and non-industrial partners. Dr. Freckmann received the “Leadership Award” of the Diabetes Technology Society in 2020.
In addition, he is chair of the IFCC Working Group on Continuous Glucose Monitoring (WG-CGM), member of the managing board of the diabetes technology working group (AGDT), the commission for laboratory diagnostics (KLD) and the Point-of-Care-Testing (POCT) working group of the German Diabetes Association.